Coprelotamab
- Generic Name
- Coprelotamab
- Drug Type
- Biotech
- CAS Number
- 2348469-84-9
- Unique Ingredient Identifier
- XQ7509L801
- Background
Coprelotamab is under investigation in clinical trial NCT04170595 (Clinical Study of Recombinant Anti-her2 Humanized Monoclonal Antibody for Injection).
Clinical Trial of Comparative Study of GB221 Pharmacokinetics
Phase 1
Completed
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- Genor Biopharma Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT04175171
- Locations
- 🇦🇺
Linear Clinical Research Limited, Nedlands, Western Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath